Oncostatin M Receptor antibody (N-Term)
Quick Overview for Oncostatin M Receptor antibody (N-Term) (ABIN635957)
Target
See all Oncostatin M Receptor (OSMR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- OSMR antibody was raised against the N terminal of OSMR
-
Purification
- Affinity purified
-
Immunogen
- OSMR antibody was raised using the N terminal of OSMR corresponding to a region with amino acids YQSEVLAERLPLTPVSLKVSTNSTRQSLHLQWTVHNLPYHQELKMVFQIQ
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
OSMR Blocking Peptide, (ABIN936190), is also available for use as a blocking control in assays to test for specificity of this OSMR antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of OSMR antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Oncostatin M Receptor (OSMR)
-
Alternative Name
- OSMR
-
Background
- Oncostatin M is a member of the IL6 family of cytokines. Functional receptors for IL6 family cytokines are multisubunit complexes involving members of the hematopoietin receptor superfamily. Many IL6 cytokines utilize gp130 as a common receptor subunit. OSM binds to the gp130 receptor subunit and, in association with the leukemia inhibitory factor receptor, induces a proliferative response in permissive cells.
-
Molecular Weight
- 110 kDa (MW of target protein)
-
Pathways
- JAK-STAT Signaling, Growth Factor Binding
Target
-